
Centene Corporation CNC
$ 45.05
2.83%
Annual report 2025
added 02-17-2026
Centene Corporation Gross Profit 2011-2026 | CNC
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Centene Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.2 B | 17.1 B | 17.6 B | 16.9 B | 14.5 B | - | 8.84 B | 8.42 B | 5.8 B | 5.54 B | 2.75 B | 1.9 B | 1.21 B | 706 M | 938 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.6 B | 706 M | 8.32 B |
Gross Profit of other stocks in the Health care industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Triple-S Management Corporation
GTS
|
14.3 M | - | 0.28 % | $ 847 M | ||
|
Magellan Health, Inc.
MGLN
|
119 M | - | -0.19 % | $ 2.49 B | ||
|
CVS Health Corporation
CVS
|
45.5 B | $ 81.05 | 0.68 % | $ 103 B | ||
|
Molina Healthcare
MOH
|
2.3 B | $ 150.75 | 4.13 % | $ 7.96 B | ||
|
NovoCure Limited
NVCR
|
488 M | $ 13.43 | 0.98 % | $ 1.5 B | ||
|
UnitedHealth Group Inc.
UNH
|
55.7 B | $ 291.69 | 0.86 % | $ 265 B |